Advertisement

Human Physiology

, Volume 44, Issue 8, pp 855–859 | Cite as

Trigeminal Neuralgia Associated with Herpes Zoster

  • M. A. Piradov
  • M. Yu. MaksimovaEmail author
  • N. A. Sineva
Article
  • 2 Downloads

Abstract

Ophthalmic nerve neuropathy (the first branch of the trigeminal nerve, CN V:V1) is the most common manifestation of herpes zoster. Ophthalmic nerve neuropathy occurs in 20% of herpes zoster cases. There are three types of pain in trigeminal neuralgia: chronic burning pain, paroxysmal pain, and pain resulting from non-painful stimulation. Cutaneous hypoesthesia, anesthesia and dysesthesia develop. Postherpetic neuralgia is characterized by pain persisting for 3 months and longer after herpetic eruption. Combination therapy including early administration of antiviral drugs and tricyclic antidepressants has been approved as the most effective.

Keywords:

herpes zoster trigeminal neuralgia 

REFERENCES

  1. 1.
    Weinberg, J.M., Herpes zoster: epidemiology, natural history and common complications, J. Am. Acad. Dermatol., 2007, vol. 57, no. 6, pp. 130–135. PMID 18021864. doi http://dx.doi.org/10.1016/j.jaad. 2007.08.046CrossRefGoogle Scholar
  2. 2.
    Carbone, V., Leonardi, A., Pavese, M., et al., Herpes zoster of the trigeminal nerve: a case report and review of literature, Minerva Stomatol., 2004, vol. 53, nos. 1–2, pp. 49–59. PMID 15041920.Google Scholar
  3. 3.
    Okeson, J.P., Bell’s Oral and Facial Pain, Chicago, Il: Quintessence, 2014, 7th ed.Google Scholar
  4. 4.
    Shishov, A.S. and Smirnov, Yu.K., Epidemiology of herpes zoster. The patient with herpes zoster as a source of the chickenpox infection, Zh. Mikrobiol., Epidemiol. Immunobiol., 1987, no. 12, pp. 45–50.Google Scholar
  5. 5.
    Suslina, Z.A. and Maksimova, M.Yu., Nevrologicheskie proyavleniya opoyasyvayushchego gerpesa (Neurologic Manifestations of Herpes Zoster), Moscow: Praktika, 2014.Google Scholar
  6. 6.
    Maksimova, M.Y., Sineva, N.A., and Vodop’ya-nov, N.P., Herpes zoster-induced neuralgia (neuropathy), Ter. Arkh., 2014, vol. 86, no. 11, pp. 93–99. PMID 25715496.Google Scholar
  7. 7.
    Maksimova, M.Y., Sineva, N.A., and Vodop’ya-nov, N.P., Postherpetic neuralgia (neuropathy) caused by herpes zoster infection, Farmateka, 2013, no. 10, pp. 58–62.Google Scholar
  8. 8.
    Yung, B.F., Jonson, R.W., Griffin, D.R., et al., Risk factors for postherpetic neuralgia in patients with herpes zoster, Neurology, 2004, vol. 62, pp. 1545–1551. PMID 15136679.CrossRefGoogle Scholar
  9. 9.
    Attal, N., Cruccu, G., Baron, R., et al., EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision, Eur. J. Neurol., 2010, vol. 17, no. 9, p. 1113-e88. PMID 20402746. doi 10.1111/j.1468-1331.2010.02999.xCrossRefGoogle Scholar
  10. 10.
    Kukushkin, M.L. and Reshetnyak, V.K., Dysregulation mechanisms of pathological pain, in Dizregulyatsionnaya patologiya (Dysregulation Pathology), Kryzhanovskii, G.N., Eds., Moscow: Meditsina, 2002, pp. 616–623.Google Scholar
  11. 11.
    Dworkin, R.H., Johnson, R.W., Breuer, J., et al., Recommendations for the management of herpes zoster, Clin. Infect. Dis., 2007, vol. 44, suppl. 1, pp. S1–S26. PMID 17143845. doi 10.1086/510206CrossRefGoogle Scholar

Copyright information

© Pleiades Publishing, Inc. 2018

Authors and Affiliations

  • M. A. Piradov
    • 1
    • 2
  • M. Yu. Maksimova
    • 1
    • 2
    Email author
  • N. A. Sineva
    • 2
  1. 1.Research Center of NeurologyMoscowRussia
  2. 2.Yevdokimov Moscow State University of Medicine and DentistryMoscowRussia

Personalised recommendations